Intervention not reported
Senstivity analysis 3: Worst case scenario imputation · lower gastrointestinal surgery
1 finding from 1 review
Intervention not reported
Senstivity analysis 4: Best case scenario imputation · lower gastrointestinal surgery
1 finding from 1 review
Episodes of abdominal distention > 2 cm · exclusively formula‐fed preterm or low birth weight infants
1 finding from 1 review
Episodes of gastric residuals3 > 50% of last feed remaining · exclusively formula‐fed preterm or low birth weight infants
1 finding from 1 review
Days until 420 joules per kilogram · exclusively formula‐fed preterm or low birth weight infants
1 finding from 1 review
Necrotising enterocolitis · exclusively formula‐fed preterm or low birth weight infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality before hospital discharge · exclusively formula‐fed preterm or low birth weight infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Invasive infection (any organism) · exclusively formula‐fed preterm or low birth weight infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment failure · Adult patients with cancer who develop a low‐risk febrile neutropaenic event
Outpatients showed no clear difference in treatment failure compared with inpatients ‐ adults (moderate certainty).
1 finding from 1 review
Adverse drug reactions · Children with cancer who develop a low‐risk febrile neutropaenic event
Outpatients showed no clear difference in adverse drug reactions compared with inpatients ‐ children (low certainty).
1 finding from 1 review
Duration of neutropaenia (days) · Children with cancer who develop a low‐risk febrile neutropaenic event
1 finding from 1 review
Length of hospitalisation (days) · Children with cancer who develop a low‐risk febrile neutropaenic event
1 finding from 1 review
Duration of antimicrobial treatment (days) · Children with cancer who develop a low‐risk febrile neutropaenic event
1 finding from 1 review
All‐cause mortality · Adult patients with cancer who develop a low‐risk febrile neutropaenic event
Outpatients showed no clear difference in mortality compared with inpatients ‐ adults (moderate certainty).
1 finding from 1 review
Fever clearance time · Adult patients with cancer who develop a low‐risk febrile neutropaenic event
1 finding from 1 review
Adverse drug reactions · Adult patients with cancer who develop a low‐risk febrile neutropaenic event
Outpatients showed no clear difference in adverse drugs reactions compared with inpatients ‐ adults (low certainty).
1 finding from 1 review
Duration of neutropaenia (days) · Adult patients with cancer who develop a low‐risk febrile neutropaenic event
1 finding from 1 review
Length of hospitalisation (days) · Adult patients with cancer who develop a low‐risk febrile neutropaenic event
1 finding from 1 review
Treatment failure · Children with cancer who develop a low‐risk febrile neutropaenic event
Outpatients showed no clear difference in treatment failure compared with inpatients ‐ children (moderate certainty).
1 finding from 1 review
All‐cause mortality · Children with cancer who develop a low‐risk febrile neutropaenic event
Outpatients showed no clear difference in mortality compared with inpatients ‐ children (moderate certainty).
1 finding from 1 review